An irreversible inhibitor of S-adenosyl-L-methionine decarboxylase (AdoMetDC), 5'-{[(Z)-4-amino-2-butenyl] methylamino}-5'-deoxyadenosine (MDL 73811), was found to cure Trypanosoma brucei brucei and multidrug-resistant T. b. rhodesiense infections in mice [Bitonti, Byers, Bush, Casara, Bacchi, Clarkson, McCann & Sjoerdsma (1990) Antimicrob. Agents Chemother. 34, 1485-1490]. Doses of this drug which resulted in a rapid clearance of parasites from T. b. brucei-infected rats resulted in plasma levels of 50-60,tM-MDL 73811 and an intratrypanosomal MDL 73811 concentration of 1.9 mm within 10 min of administration [Byers, Bush, McCann & Bitonti (1991) Biochem. J. 274, 527-533]. Based on this finding we speculated that MDL 73811, which is an adenosine analogue, is a substrate for the trypanosome active purine transport system. We now report evidence that supports this hypothesis. MDL 73811 uptake by T. b. brucei in vitro was time-and temperature-dependent and was saturable over a time course in which MDL 73811 metabolism was undetectable, suggesting that MDL 73811 uptake is a transport-mediated phenomenon. Inhibition of MDL 73811 uptake by purine nucleosides is consistent with the drug being a substrate for the trypanosome purine transport system. The accumulation of MDL 73811 by cultured L1210 mouse leukaemia cells was significantly less than by trypanosomes exposed to the same pharmacologically relevant concentrations of MDL 73811. Given that the half-life of MDL 73811 in the plasma of rats and mice is approx. 10 min, it seems likely that the existence of a highly active parasite transport system for MDL 73811 is crucial for the sensitivity of trypanosomes towards MDL 73811 in vivo, and that the absence of active transport of MDL 73811 by the host's cells may play a role in the selectivity of this drug.
INTRODUCTION
Administration of 5'-{[(Z)-4-amino-2-butenyl]methylamino}-5'-deoxyadenosine (MDL 73811), an enzyme-activated irreversible inhibitor of S-adenosyl-L-methionine decarboxylase (AdoMetDC), a key enzyme in the synthesis of spermidine, cures mice infected with the African trypanosome Trypanosoma brucei brucei (Bitonti et al., 1990) . We reported recently that administration of MDL 73811 to T. b. brucei-infected rats results in a 700% decrease in parasitaemia within 1 h, and a complete disappearance of parasites by 5 h (Byers et al., 1991) . The decrease in parasitaemia was preceded by complete inhibition of AdoMetDC activity by 10 min after injection of MDL 73811. The half-life of the drug and the peak plasma concentration after a single intraperitoneal injection of 50 mg of MDL 73811/kg, a dose which results in a rapid decrease in parasitaemia, were found to be approx. 10 min and 50 /SM respectively. The intracellular concentration of MDL 73811 in trypanosomes 10 min after injection with 25 mg of the drug/kg was found to be 1.9 mm. Given the low plasma concentration of this drug, the high intracellular concentration of MDL 73811 suggested that trypanosomes have an active transport system for which MDL 73811 is a substrate. Because the half-life of MDL 73811 is approx. 10 min, the existence of a highly active transport system is likely to be crucial for the sensitivity of the trypanosomes towards MDL 73811 in vivo.
Many protozoan parasites, including African trypanosomes, cannot synthesize purines (reviewed in Hammond & Gutteridge, 1984) and, therefore, they are dependent on exogenous purines and have a specific, active transport system for purine nucleosides (Hammond & Gutteridge, 1984; Gottlieb & Dwyer, 1988) . Because MDL 73811 is an adenosine analogue, we hypothesized previously that the purine nucleoside transport system may be involved in the uptake of MDL 73811 by trypanosomes (Byers et al., 1991 [3H]MDL 73811 was purified by passing the tritiated material from New England Nuclear on to a pre-column packed with Partisil 10-SCX (4.6 mm x 100 mm) and then on to a Whatman Partisil 10-SCX (4.6 mm x 250 mm) column using a 0.25 Mammonium formate (pH 4) buffer containing 100% acetonitrile delivered at 2 ml/min at 35 'C. Fractions (I ml) were collected and the elution of MDL 73811 was monitored at 254 nm using (Lanham & Godfrey, 1970 ) equilibrated with 90 mM-Tris/HCI, pH 7.8, containing 50 mM-NaCl and 2% glucose (TSG), and then washed several times in TSG before use in uptake studies.
Separation and quantification of MDL 73811
MDL 73811 was separated and quantified as described previously (Byers et al., 1991) . A reverse-phase chromatography system using an h.p.l.c. apparatus from Beckman Instruments was used to separate MDL 73811. The sample was passed first over a Waters Bondpak C18 pre-column and then on to a Beckman Ultrasphere Ion Pairing 5 1um C18 (250 mm x 4.6 mm) column (Byers et al., 1991 ) using a sodium phosphate buffer system described by Wagner et al. (1982) . U.v. absorption at 254 nm was used to detect MDL 73811 and an on-line radioactivity detector from Radiomatic was used to detect and quantify 3H in the sample.
Uptake of MDL 73811 by trypanosomes and L1210 cells
Purified trypanosomes were washed twice in Dulbecco's modified Eagle's medium (pH 7.5; Gibco) supplemented with 2 mM-glutamine, 0.2 % glucose, 12 ,sg of penicillin/ml, 12 ,ug of streptomycin/ml and 30 mM-Hepes, and then suspended in this medium supplemented with 1 % BSA (Fraction V; CalBiochem) at 2 x 109 trypanosomes/ml in Microfuge tubes. This cell suspension was incubated in a shaking water bath at 37°C for 1-3 min 
RESULTS
Uptake of MDL 73811 into trypanosomes was both timeand temperature-dependent (Fig. 1) . Uptake at 37°C was approximately linear (correlation coefficient = 0.988) for up to 7 min. Uptake of the drug at 4°C proceeded at a much lower rate than at 37°C, and the uptake at the lower temperature appeared to be linear for at least 5 min. Trypanosomes exposed to 40 4uM-MDL 73811 for 5 min at 37°C were > 95 % viable, as determined by microscopic observation. The remainder of the uptake experiments were carried out at 37°C over a time period of 5 min or less.
Trypanosome uptake of MDL 73811 was saturable (Fig. 2 MDL 74281 is a metabolic product produced by the catalytic action of AdoMetDC on MDL 73811 during inhibition of that enzyme (Casara et al., 1989) , and MDL 73581, which is an analogue of MDL 73811, is an inhibitor of AdoMetDC (Fig. 3) . MDL 73811 uptake was inhibited by MDL 74281 and MDL 73581 (Fig. 4a) . MDL 73811 uptake was also inhibited by the purine nucleosides adenosine and guanosine, but not by the pyrimidine nucleoside cytosine (Fig. 4a) . Adenine and guanine were also inhibitors of this uptake (Fig. 4b) , although these purine bases did not inhibit as well as their respective nucleosides. The nucleoside analogue nitrobenzylthioinosine, an inhibitor of nucleoside transport in mammalian cells, was a very poor inhibitor of MDL 73811 uptake relative to the natural nucleosides (Fig. 4b) . The inhibition of MDL 73811 uptake by the structural analogues increased the Km of uptake without altering the Vmax and therefore is consistent with competitive inhibition.
DISCUSSION
It appears clear that MDL 73811 enters T. b. brucei via a transport-mediated mechanism. The uptake of this drug by the trypanosomes was saturable, temperature-sensitive and inhibited by synthetic and natural structural analogues, all of which are Vol. 283 (Byers et al., 1991) and the LD50 for MDL 73811 in mice is over 300 mg/kg (T. L. Byers, P. Casara & A. J. Bitonti, unpublished work) .
The inability of many parasitic protozoa to synthesize purines de novo has long been appreciated, and has resulted in the targeting of this deficiency in the design of chemotherapeutic agents for specific parasitic diseases (Marr & Berens, 1983) . Although the uptake of purines and their bases by parasitic protozoa has not been extensively studied, it is generally accepted that this uptake is due to an active transport system developed by these organisms to exploit the host. Our data indicate that we have successfully exploited the dependence of African trypanosomes on exogenous purine sources to deliver the antitrypanosomal agent MDL 73811 to the target organism.
MDL 73811 concentrations in trypanosomes were found to be over 30-fold higher than those in host plasma within 10 min after intraperitoneal injection of infected rats with a minimal effective antitrypanosomal dose. Since the half-life of MDL 73811 in these animals was less than 10 min, it is likely that the uptake of the drug by an active mechanism by the trypanosome purine transport system may be crucial for the sensitivity of the trypanosomes towards MDL 7381 1. In addition, the active transport of MDL 73811 by trypanosomes, the short plasma half-life of this drug and the relatively low accumulation of MDL 73811 by mammalian cells probably play a role in the selective antitrypanosomal effects of MDL 7381 1.
